What is IRIX stock price today?

IRIX (Iridex Corp) stock is trading at $1.02 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is IRIX stock going up or down today?

IRIX stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy IRIX stock now?

The decision to buy IRIX depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is IRIX a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for IRIX based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is IRIX stock overvalued or undervalued?

Use our DCF valuation calculator to determine if IRIX is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is IRIX's P/E ratio?

P/E ratio data for IRIX will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is IRIX's market cap?

IRIX (Iridex Corp) has a market capitalization of $0.02 billion, making it a small-cap stock.

What is IRIX's price to book ratio?

IRIX trades at a price-to-book (P/B) ratio of 269.77, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does IRIX pay dividends?

IRIX does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is IRIX's dividend yield?

IRIX does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is IRIX stock a good long-term investment?

IRIX's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is IRIX's revenue growth rate?

IRIX has shown revenue growth of 0.2% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

IRIX is currently operating at a loss. Some companies prioritize growth over profitability in early stages. Review our financial analysis for detailed insights.

What are the risks of investing in IRIX?

Key risks for IRIX include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does IRIX compare to its competitors?

Compare IRIX to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize IRIX's performance and positioning.

What is IRIX's stock price target for 2026?

Our AI model provides price targets for IRIX based on fundamental analysis: Bull case $1.33 (+30%), Base case $1.17 (+15%), Bear case $0.92 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about IRIX?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for IRIX. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is IRIX's next earnings report?

IRIX reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

IRIX - Iridex Corp

NYSE * Health Care * Health Care Equipment & Supplies

$1.02

$-0.01 (-0.97%)

About Iridex Corp

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. In addition, it offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform transscleral laser therapy; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products that are used for endophotocoagulation. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics through direct and independent sales force in the United States, as well as through independent distributors internationally. It operates in the United States, Europe, the Middle East, Africa, the Asia/Pacific region, and the Americas. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

IRIX Key Statistics

Market Cap

$17.83M

P/B Ratio

269.77

EPS

$-0.26

Revenue Growth

+0.2%

Profit Margin

-0.1%

Employees

How IRIX Compares to Peers

IRIX has the fastest revenue growth among competitors

IRIX is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 1

Margin Rank

of 2

Growth Rank

of 2

Size Rank

of 2

Company	Market Cap	P/E	Growth	Margin	Compare
IRIX(This stock)	$17.83M	N/A	0%	-0.1%	-
AMZNAmazon Com	$2.68T	34.7	0%	0.1%	vs AMZN

Iridex Corp Company Information

Headquarters: California; U.S.A
Website: www.iridex.com
Sector: Health Care
Industry: Health Care Equipment & Supplies

IRIX - Iridex Corp

About Iridex Corp

IRIX Key Statistics

How IRIX Compares to Peers

Iridex Corp Company Information

IRIX Lician Score

IRIX Financial Snowflake

Upcoming Events for IRIX